The discovery of high affinity and metabolically stable allosteric cyclin-dependent kinase 2 (CDK2) inhibitors from screening through lead optimizationErik B. Faber, Gunda I. Georg, David J. Burban et al.|ChemRxiv|2022Cited by 1
The discovery of high affinity and metabolically stable allosteric cyclin-dependent kinase 2 (CDK2) inhibitors from screening through lead optimizationErik B. Faber, Gunda I. Georg, Nan Wang et al.|ChemRxiv|2022Cited by 0